PVH
6.10.2020 18:02:13 CEST | Business Wire | Press release
PVH Europe, the global headquarters of Tommy Hilfiger and the European offices of Calvin Klein, both owned by PVH Corp. [NYSE: PVH], announces the installation of what is believed to be the world’s most powerful* currently operational solar roof at its state-of-the-art Warehouse and Logistics Center in Venlo, the Netherlands. Generated by more than 48,000 solar panels, the solar roof covers the Center’s electricity footprint, as well as indirectly providing 100% of all energy for PVH Europe’s warehouses, offices and stores in the Netherlands via the Dutch public power network. PVH Europe’s energy partner, Eneco, has certified that all energy needed to power these buildings is generated by the new rooftop installation. The Venlo Warehouse and Logistics Center is owned by Heylen Warehouses, a Belgian logistics real estate company, in a joint venture with AG Real Estate, and retained IZEN as the technical installation partner for the roof.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201006005513/en/
This milestone marks another step in PVH’s journey to procure 100% of its electricity from renewable sources for its offices, warehouses and stores, and to drive a 30% reduction in supply chain carbon emissions by 2030. This work is linked to PVH’s science-based emissions target aligned with the most ambitious level of decarbonization as set out by the Paris Agreement. It is also one of the priorities outlined in the company’s Forward Fashion corporate responsibility strategy, which aims to reduce negative impacts to zero, increase positive impacts to 100% and improve the over 1 million lives across the company’s value chain.
Key Facts:
- The Venlo warehouse is PVH Europe’s main distribution center covering 110,000m2 .
- Awarded a BREEAM (Building Research Establishment Environmental Assessment Method) sustainability rating of “Very Good”.
- The world’s most powerful solar roof, with a capacity to generate 18 MWp (megawatt peak).
- Facilitated by over 48,000 high performance solar panels.
- Fully powers all PVH Europe owned stores, warehouses and offices in the Netherlands.
“This is an incredible milestone for our Warehouse and Logistics Center in Venlo and for PVH Europe’s sustainability journey,” said Martijn Hagman, CEO ,Tommy Hilfiger Global and PVH Europe. “We have participated in the installation of what we believe is now the world’s most powerful, fully operational solar roof – a huge stride in our commitment to be powered by 100% renewable electricity by 2030 and reduce supply chain emissions by 30% by 2030. This would not have been possible without a best-in-class team of such talented, passionate, and devoted PVH associates.”
At present, up to 600,000 pieces of TOMMY HILFIGER and CALVIN KLEIN product are distributed daily from the PVH Europe Warehouse and Logistics Center in Venlo to points of sale, including owned and operated stores in Europe, the Middle East and Africa, and direct to customers. The warehouse’s Very Good rating by BREEAM incorporates exemplary standards for energy, water, transport, materials, waste, pollution, ecology, health and well-being. This is reflected through energy efficient lighting in 100% of the space, the use of 100% FSC (Forest Stewardship Council) certified packaging and 100% recycling of all cardboard, plastics and printed material.
PVH is a member of RE100, the corporate renewable electricity initiative led by the Climate Group, and has committed to RE100 to procure 100% of its electricity from renewable sources by 2030.
Sam Kimmins, Head of RE100 at the Climate Group said: “Congratulations to PVH on the finalization of the Venlo solar rooftop. This is another exciting step in their global work and partnership towards their 2025 RE100 target. It raises the bar once more for on-site renewables.”
“ We believe that logistic buildings will be the next generation of solar power plants,” said Philippe Deschilder, CEO of Heylen Warehouses. “The partnership with PVH Europe for the solar roof project supports our ambition to invest in renewable energy, creating added value for our customers by enabling them to reduce their carbon footprint.”
About PVH Corp.
PVH is one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our brand portfolio includes the iconic CALVIN KLEIN , TOMMY HILFIGER , Van Heusen , IZOD , ARROW, Warner’s , Olga and Geoffrey Beene brands, as well as the digital-centric True&Co. intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 40,000 associates operating in over 40 countries and $9.9 billion in annual revenues. That's the Power of Us. That’s the Power of PVH.
Follow us on Facebook , Instagram , Twitter and LinkedIn .
About RE100
RE100 is a global initiative bringing together the world’s most influential businesses committed to 100% renewable power. Led by the Climate Group in partnership with CDP , the group has a total revenue of over US$5.4 trillion and operates in a diverse range of sectors. Together, they send a powerful signal to policymakers and investors to accelerate the transition to a clean economy. #RE100
*PVH defines the “world’s most powerful solar roof” as the most powerful solar roof that is currently operational and installed on one singular structure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom